K201052

Substantially Equivalent

KLS Martin Individual Patient Solutions (IPS) Planning System

Applicant: KLS-Martin L.P.
Product code: PPT
Advisory panel: Neurology
Date received: 2020-04-21
Decision date: 2020-08-31
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Jacksonville, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.